SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Personalized Medicine: Molecular Dx
An SI Board Since December 2008
Posts SubjectMarks Bans
60 14 0
Emcee:  rkrw Type:  Unmoderated
Introduction Compact
Repository for Molecular Dx.

Tailwinds seem to be moving in this direction.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60Nature blurb on studies of complete response outliers in failed oncology trials:tuck-4/23/2013
59Cleveland Clinic study challenges accepted notions about “personalized” cancer dDewDiligence_on_SI-12/13/2012
58Not hot off the press but still relevant, I think... Next-gen sequencing in cliTheSlowLane-9/28/2012
57New Report: Molecular Diagnostics Instruments & Reagents Market Forecasts toTheSlowLane-9/28/2012
56First approved patent for 23andMe on susceptibility to Parkinson's disease idos-5/31/2012
55Personalized Cancer Care in an Age of Anxiety onlinelibrary.wiley.comidos-4/5/2012
54This paper throws some cold water on personalized medicine, at least for cancer:tuck-3/20/2012
53I dislike the word <i>theranostics</i>.DewDiligence_on_SI-1/13/2012
52Cancer Theranostics - Potential Applications of Cancer Biomarkers This blogTonny Johnson-1/13/2012
51Interesting take on personalized medicine by yet another biotech startup. I findSteve Lokness-11/9/2011
50Duke researcher's fraudulent personalized medicine (biomarker) studies: piptuck-7/11/2011
49From Matt Herper’s blog ( blogs.forbes.com ): >> Clinical trials in canceDewDiligence_on_SI-6/6/2011
48Doesn't look as though we'll be doing personalized medicine for breast ctuck-4/6/2011
47Very promising presentation this morning by CALP; jpmorgan.metameetings.com FoSteve Lokness-1/13/2011
46<i> Caliper Life Sciences to Acquire Cambridge Research & InstrumentatSteve Lokness-12/10/2010
45<b>Myriad Takes Over Testing Platform from Melanoma Diagnostics</b> idos-12/9/2010
44Plavix Genetic Studies Show Mixed Results: siliconinvestor.comDewDiligence_on_SI-8/30/2010
43Pharmacy benefit managers leading the charge for personalized medicine? signonstuck-8/19/2010
42The FDA is having a public meeting to discuss regulation of personalized medicinidos-7/16/2010
41<i> Response Genetics Signs Agreement with GlaxoSmithKline to Provide ProSteve Lokness-5/11/2010
40More from Reuters... UPDATE 1-Testing lung tumors tailors chemotherapy sim1-4/19/2010
39Promise in the battle against a top killer Lung cancer resim1-4/19/2010
38wsj.com Licenses Drive Gene Debate Duke Study Claims Staked on Genome Could Derkrw-4/15/2010
37Forbes’ Matt Herper concurs with rkrw on the MYGN case: siliconinvestor.com :-DewDiligence_on_SI-4/1/2010
36Test Predicts Which Patients Benefit From $6 Billion MS Drugs March 28, 2010, 2:rkrw-3/29/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News